T2STIR pituitary

Ian T Mark1, Dominik Nickel2, Peter Kollasch2

  • 1From the Mayo Clinic, Department of Radiology (I.T.M., G.B., P.J.F., A.M., S.A.M.), Siemens Medical Solutions USA (P.K., K.D.), Rochester, MN and Siemens Healthineers AG (D.N.), Research & Clinical Translation, Magnetic Resonance, Erlangen Germany. Mark.Ian@mayo.edu.

概括

这项研究引入了修改的T2加权STIR序列,以更好地检测垂体腺瘤. 该技术通过使正常的垂体组织在MRI扫描上显得更暗来提高瘤的可见性.